Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 312

1.

Plasma vitamin D levels, menopause, and risk of breast cancer: dose-response meta-analysis of prospective studies.

Bauer SR, Hankinson SE, Bertone-Johnson ER, Ding EL.

Medicine (Baltimore). 2013 May;92(3):123-31. doi: 10.1097/MD.0b013e3182943bc2. Review.

2.

Effectiveness and safety of vitamin D in relation to bone health.

Cranney A, Horsley T, O'Donnell S, Weiler H, Puil L, Ooi D, Atkinson S, Ward L, Moher D, Hanley D, Fang M, Yazdi F, Garritty C, Sampson M, Barrowman N, Tsertsvadze A, Mamaladze V.

Evid Rep Technol Assess (Full Rep). 2007 Aug;(158):1-235. Review.

3.

Serum 25-hydroxyvitamin D and breast cancer risk: a meta-analysis of prospective studies.

Wang D, Vélez de-la-Paz OI, Zhai JX, Liu DW.

Tumour Biol. 2013 Dec;34(6):3509-17. doi: 10.1007/s13277-013-0929-2. Epub 2013 Jun 27.

PMID:
23807676
4.

The relationship between breast cancer treatment, tumour type and vitamin D level in pre- and postmenopausal women.

Streb J, Glanowska I, Streb A, Szpor J, Kryka K, Potocki P, Wójcik M, Jach R.

Neuro Endocrinol Lett. 2017 Dec;38(6):437-440.

PMID:
29298285
5.

Serum 25-hydroxyvitamin D and risk of breast cancer: results of a large population-based case-control study in Mexican women.

Fedirko V, Torres-Mejía G, Ortega-Olvera C, Biessy C, Angeles-Llerenas A, Lazcano-Ponce E, Saldaña-Quiroz VA, Romieu I.

Cancer Causes Control. 2012 Jul;23(7):1149-62. doi: 10.1007/s10552-012-9984-z. Epub 2012 May 24.

PMID:
22622862
6.

Circulating levels of 25-hydroxyvitamin D and risk of breast cancer: a nested case-control study.

Scarmo S, Afanasyeva Y, Lenner P, Koenig KL, Horst RL, Clendenen TV, Arslan AA, Chen Y, Hallmans G, Lundin E, Rinaldi S, Toniolo P, Shore RE, Zeleniuch-Jacquotte A.

Breast Cancer Res. 2013 Feb 26;15(1):R15. doi: 10.1186/bcr3390.

7.

Plasma 25-hydroxyvitamin D and premenopausal breast cancer risk in a German case-control study.

Abbas S, Chang-Claude J, Linseisen J.

Int J Cancer. 2009 Jan 1;124(1):250-5. doi: 10.1002/ijc.23904.

8.

Circulating 25-hydroxyvitamin D and postmenopausal breast cancer survival: Influence of tumor characteristics and lifestyle factors?

Vrieling A, Seibold P, Johnson TS, Heinz J, Obi N, Kaaks R, Flesch-Janys D, Chang-Claude J.

Int J Cancer. 2014 Jun 15;134(12):2972-83. doi: 10.1002/ijc.28628. Epub 2013 Dec 7.

9.

Plasma 25-hydroxyvitamin D and risk of breast cancer in the Nurses' Health Study II.

Eliassen AH, Spiegelman D, Hollis BW, Horst RL, Willett WC, Hankinson SE.

Breast Cancer Res. 2011 May 11;13(3):R50. doi: 10.1186/bcr2880.

10.

Circulating 25-hydroxyvitamin D and risk of lung cancer: a dose-response meta-analysis.

Chen GC, Zhang ZL, Wan Z, Wang L, Weber P, Eggersdorfer M, Qin LQ, Zhang W.

Cancer Causes Control. 2015 Dec;26(12):1719-28. doi: 10.1007/s10552-015-0665-6. Epub 2015 Sep 10. Review.

PMID:
26358829
11.

Plasma 25-hydroxyvitamin D3 is associated with decreased risk of postmenopausal breast cancer in whites: a nested case-control study in the multiethnic cohort study.

Kim Y, Franke AA, Shvetsov YB, Wilkens LR, Cooney RV, Lurie G, Maskarinec G, Hernandez BY, Le Marchand L, Henderson BE, Kolonel LN, Goodman MT.

BMC Cancer. 2014 Jan 17;14:29. doi: 10.1186/1471-2407-14-29.

12.

A prospective study of plasma prolactin concentrations and risk of premenopausal and postmenopausal breast cancer.

Tworoger SS, Eliassen AH, Sluss P, Hankinson SE.

J Clin Oncol. 2007 Apr 20;25(12):1482-8. Epub 2007 Mar 19.

PMID:
17372279
13.

Association between plasma 25-hydroxyvitamin D and breast cancer risk.

Crew KD, Gammon MD, Steck SE, Hershman DL, Cremers S, Dworakowski E, Shane E, Terry MB, Desai M, Teitelbaum SL, Neugut AI, Santella RM.

Cancer Prev Res (Phila). 2009 Jun;2(6):598-604. doi: 10.1158/1940-6207.CAPR-08-0138. Epub 2009 May 26.

14.

The Gc2 allele of the vitamin D binding protein is associated with a decreased postmenopausal breast cancer risk, independent of the vitamin D status.

Abbas S, Linseisen J, Slanger T, Kropp S, Mutschelknauss EJ, Flesch-Janys D, Chang-Claude J.

Cancer Epidemiol Biomarkers Prev. 2008 Jun;17(6):1339-43. doi: 10.1158/1055-9965.EPI-08-0162.

15.

Plasma 25-hydroxyvitamin D and the risk of breast cancer in the European prospective investigation into cancer and nutrition: a nested case-control study.

Kühn T, Kaaks R, Becker S, Eomois PP, Clavel-Chapelon F, Kvaskoff M, Dossus L, Tjønneland A, Olsen A, Overvad K, Chang-Claude J, Lukanova A, Buijsse B, Boeing H, Trichopoulou A, Lagiou P, Bamia C, Masala G, Krogh V, Sacerdote C, Tumino R, Mattiello A, Buckland G, Sánchez MJ, Menéndez V, Chirlaque MD, Barricarte A, Bueno-de-Mesquita HB, van Duijnhoven FJ, van Gils CH, Bakker MF, Weiderpass E, Skeie G, Brustad M, Andersson A, Sund M, Wareham N, Khaw KT, Travis RC, Schmidt JA, Rinaldi S, Romieu I, Gallo V, Murphy N, Riboli E, Linseisen J.

Int J Cancer. 2013 Oct 1;133(7):1689-700. doi: 10.1002/ijc.28172. Epub 2013 Apr 22.

16.

Plasma free 25-hydroxyvitamin D, vitamin D binding protein, and risk of breast cancer in the Nurses' Health Study II.

Wang J, Eliassen AH, Spiegelman D, Willett WC, Hankinson SE.

Cancer Causes Control. 2014 Jul;25(7):819-27. doi: 10.1007/s10552-014-0383-5. Epub 2014 Apr 20.

17.

Pretreatment serum concentrations of 25-hydroxyvitamin D and breast cancer prognostic characteristics: a case-control and a case-series study.

Yao S, Sucheston LE, Millen AE, Johnson CS, Trump DL, Nesline MK, Davis W, Hong CC, McCann SE, Hwang H, Kulkarni S, Edge SB, O'Connor TL, Ambrosone CB.

PLoS One. 2011 Feb 28;6(2):e17251. doi: 10.1371/journal.pone.0017251.

18.

Premenopausal plasma 25-hydroxyvitamin D, mammographic density, and risk of breast cancer.

Bertrand KA, Rosner B, Eliassen AH, Hankinson SE, Rexrode KM, Willett W, Tamimi RM.

Breast Cancer Res Treat. 2015 Jan;149(2):479-87. doi: 10.1007/s10549-014-3247-5. Epub 2014 Dec 28.

19.

Serum 25-hydroxyvitamin D and risk of post-menopausal breast cancer--results of a large case-control study.

Abbas S, Linseisen J, Slanger T, Kropp S, Mutschelknauss EJ, Flesch-Janys D, Chang-Claude J.

Carcinogenesis. 2008 Jan;29(1):93-9. Epub 2007 Oct 31.

PMID:
17974532
20.

Blood 25-hydroxy vitamin D levels and incident type 2 diabetes: a meta-analysis of prospective studies.

Song Y, Wang L, Pittas AG, Del Gobbo LC, Zhang C, Manson JE, Hu FB.

Diabetes Care. 2013 May;36(5):1422-8. doi: 10.2337/dc12-0962.

Supplemental Content

Support Center